Tracy Chavez, PA
Payments from drug & device makers
Across 82 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$323
- GSK$321
- Novo Nordisk$130
- Lilly USA, LLC$91
- AstraZeneca$89
- Astellas Pharma US Inc$59
- plus $489 from 18 others
What the payments were for
- Food & beverage$1,501100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 19 | $323 |
| GSK | 14 | $321 |
| Novo Nordisk | 7 | $130 |
| Lilly USA, LLC | 5 | $91 |
| AstraZeneca | 6 | $89 |
| Astellas Pharma US Inc | 3 | $59 |
| Johnson & Johnson | 3 | $55 |
| Bayer | 3 | $49 |
| Exact Sciences | 3 | $43 |
| Abbott | 2 | $38 |
| Organon | 2 | $36 |
| Eisai Inc. | 2 | $33 |
| Phadia US Inc. | 2 | $32 |
| Sanofi | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Si-bone, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Merck | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $14 |
How this compares
$1,501 in reported general payments places this provider in the 70th percentile of 2,087 medical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 12 | $1,314 |
| Diclofenac Sodium | 20 | $417 |
| Levothyroxine Sodium | 22 | $373 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $361 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $360 |
| Atorvastatin Calcium | 24 | $353 |
| Amlodipine Besylate | 34 | $237 |
| Metoprolol Succinate | 18 | $232 |
| Doxycycline Monohydrate | 13 | $204 |
| Escitalopram Oxalate | 12 | $202 |
| Fluticasone Propionate | 21 | $200 |
| Pantoprazole Sodium | 15 | $171 |
| Famotidine | 16 | $168 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $143 |
| Trazodone Hcl | 21 | $135 |
Paid to pharmacies, not to this prescriber.
Other medical in Vista
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.